Sidekik’s Mission

The support of a global effort toward achieving a “closed loop” state of treatment for diabetes and obesity by advancing technology that reduces the stress and complexity of syringe and vial therapy. Our primary goal is to improve dosage accuracy, while providing information bridges between healthcare workers and family.

With a focus on economically challenged populations worldwide, Sidekik aims to improve access to more manageable and reliable care. Its goal is to reduce instances of inaccurate dosing for both insulin and GLP-1 therapies while enabling users to seamlessly share historical treatment data with their physicians.